Stock·NYSE·Industrials
Northrop Grumman Corporation (NOC)
- Market cap
- $70.98B
- P/E
- 15.30
- Dividend yield
- 1.91%
- Street target
- $608.50median of 26 analysts
- 52-week range
- $470.06 $774.00
The short version
Where NOC stands today, in four lines, and what CleaRank Financial AI makes of it.
NOC at a glance
Northrop Grumman Corporation (NOC): Hold, 55/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($527.14 and $594.31).
- Earnings NOC beat estimates in 5 of its last 6 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $35.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 15.3 against 34.0 for the Industrials sector: a discount to peers (-55%).
Figures as of October 16, 2026.
CleaRank Financial AI
Only on CleaRank
Figures we compute ourselves from NOC's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $499.63 is 5.2% below the 50-day simple moving average of $527.14.Price above its 200-day average ›
The price is 15.9% below the 200-day simple moving average of $594.31.50-day average above the 200-day ›
The 50-day average ($527.14) is 11.3% below the 200-day average ($594.31), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 10% of its 52-week range, between $470.06 and $774.00.
NOC share price
Pick a period: each tab shows how far NOC has moved over it, to the last close.
Today's trading
Where NOC sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 15.30 is 55.0% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 1.59 is 60.1% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $4.5B on revenue of $42.9B, a net margin of 10.5%.Beat estimates in most recent reports ›
NOC beat the EPS estimate in 5 of its last 6 reports.Pays a dividend ›
The trailing dividend yield is 1.91%, or $9.56 a share a year.
Key statistics
The headline figures for NOC.
As of October 16, 2026, NOC trades at $499.63, with a market value of $70.98B, a P/E ratio of 15.30 and a dividend yield of 1.91%.
What the numbers say
CleaRank Financial AI's reading of NOC's valuation, growth and risks.
Northrop Grumman Corporation (NOC) exhibits a P/E ratio of 15.30, which is significantly lower than the sector median of 34, suggesting a potential valuation discount.
Its price-to-sales ratio stands at 1.59, also below the sector average of 4.0. The company's return on equity is a strong 26.96%, considerably higher than the sector average of 17.8%. Despite these favorable valuation and profitability metrics, the company's revenue growth of 5.1% is below the sector median of 11.7%. The debt-to-equity ratio is 0.95, which is in line with the sector average. While the fundamentals appear solid, the current price action and insider selling warrant caution.
NOC against the Industrials sector
How NOC compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: NOC trades at a notable discount to sector peers (-55%), which may indicate undervaluation or specific company headwinds.
Return vs ITA: Since May 5, 2025, NOC has gained 1.3% against a gain of 27.3% for ITA.
Performance against ITA
NOC and the Industrials sector fund over the same days.
Revenue and earnings
How much NOC sells, and how much of it becomes profit.
Revenue growth: Revenue grew 2.2% in FY2025 to $42.0B, from $41.0B a year earlier.
Profit margin: The net margin was 10.0% in FY2025, down from 10.2% the year before.
Profitable: NOC earned $4.2B in FY2025.
Earnings reality check
Did NOC beat what analysts expected, and how did the stock react?
Earnings record: NOC beat the analyst estimate in 5 of the last 6 quarters.
Market reaction: The stock fell in the first session after 1 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 21, 2026after close | $6.82 | $7.68 | +12.61% | +2.54% | +7.21% |
| Apr 21, 2026after close | $6.06 | $6.14 | +1.32% | -3.52% | -5.45% |
| Jan 27, 2026after close | $6.96 | $7.23 | +3.88% | +1.53% | +3.87% |
| Jul 22, 2025after close | $6.80 | $8.15 | +19.85% | +0.84% | +1.67% |
| Apr 22, 2025after close | $6.26 | $3.32 | -46.96% | +1.85% | +3.88% |
| Jan 30, 2025after close | $6.35 | $6.39 | +0.63% | +0.81% | -3.48% |
As of October 16, 2026, NOC has beaten the analyst EPS estimate in 5 of its last 6 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 21, 2026, came in 12.61% above the estimate and the stock moved +2.54% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 48.8, in neutral territory.RSI above 50 ›
An RSI of 48.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of NOC
The score, the reasoning behind it, and what could move the price next.
Volume has been 18.3% above its average, suggesting increased trading activity around the current price levels.
Northrop Grumman Corporation (NOC) is currently trading below its 50-day SMA of $527.14 and its 200-day SMA of $594.31, indicating a bearish trend. The 14-day RSI is at 48.8, reflecting neutral momentum, while the MACD is at -10.34, suggesting downward pressure. The current price of $499.63 is above the 20-day EMA of $496.23, which may offer near-term support. Resistance is indicated by the 50-day SMA. The stock's positioning below longer-term moving averages suggests that the current upward momentum may be limited without a significant catalyst. Investors should monitor the 20-day EMA as a potential short-term support level.
Strong Q3 Earnings Beat ›
Northrop Grumman Corporation (NOC) exceeded Q3 earnings estimates by 12.61% on July 21, 2026, with EPS of $7.68 vs $6.82, driving a 2.54% stock price increase and signaling operational strength.
Source: Company PRPositive Analyst Initiation ›
Rothschild & Co initiated coverage with a 'Buy' rating on October 6, 2026, suggesting potential upside and confidence in the company's future performance.
Source: Analyst ReportDividend Payment ›
Northrop Grumman Corporation (NOC) pays a quarterly dividend, providing a modest income stream to shareholders with a current yield of 1.91%.
Source: Company Filings
Moderate Insider Selling ›
Insiders have sold a net $35.5 million in stock with no reported purchases, indicating a moderate sell signal and potentially reduced conviction from management.
Source: Insider TransactionsAnalyst Downgrade ›
RBC Capital downgraded NOC from 'Outperform' to 'Sector Perform' on October 2, 2026, citing potential headwinds or a reassessment of the stock's risk-reward profile.
Source: Analyst Report
- Monitor the 50-day SMA ($527.14) and 200-day SMA ($594.31) as key resistance levels for Northrop Grumman Corporation (NOC). A sustained move above these averages would be required to signal a significant shift in the stock's trend.
Technical indicators
Momentum and trend for NOC, from its daily closes.
As of October 16, 2026, with NOC at $499.63, its 14-day RSI is 48.8 (neutral territory), its 50-day simple moving average is $527.14 and its 200-day is $594.31.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What NOC moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, NOC's 1-year correlation of daily returns is +0.04 with S&P 500 (SPY), -0.07 with Nasdaq 100 (QQQ), +0.03 with Bitcoin (BTC) and +0.20 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
14 of 26 analysts rate it a buy or strong buy, 11 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $608.50 is 21.8% above the price.More buy ratings than three months ago ›
14 of 26 rate it a buy now, against 14 of 23 three months ago.
NOC Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | TD Cowen | Maintains | Hold |
| Oct 9, 2026 | Barclays | Initiates | Underweight |
| Oct 6, 2026 | Rothschild & Co | Initiates | Buy |
| Oct 2, 2026 | RBC Capital | Downgrade | Sector Perform |
| Sep 23, 2026 | Bernstein | Maintains | Market Perform |
| Sep 15, 2026 | Guggenheim | Initiates | Buy |
As of October 16, 2026, 26 Wall Street analysts cover NOC: 14 rate it a buy or strong buy, 11 a hold and 1 a sell or strong sell. Their 12-month price targets range from $419.00 to $815.00, with a median of $608.50, 21.8% above the price of $499.63.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NOC trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NOC's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NOC tends to move, against the market and on its own.
The long record
NOC's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.51% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 36.0%, from March 2026 to October 2026; the price is still 33.6% below that peak.Most 1-year holds ended higher ›
71% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $26,756, against $42,525 in the S&P 500 (SPY).
NOC Drawdowns & Recovery
As of October 16, 2026, NOC's worst peak-to-trough fall over the last 10 years with dividends reinvested was -36.0% (March 2026 to October 2026); it is still 33.6% below that peak, and 71% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NOC in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NOC trailed the S&P 500 over this period: $26,756 against $42,525.
A $10,000 investment in NOC in October 2016 would be worth about $26,756 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NOC, and which have not.
Strongest month, February: an average of +4.34%, up in 8 of 10 years.
Weakest month, December: an average of -1.72%, up in 4 of 10 years.
This month, October: has averaged +0.58%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NOC's strongest calendar month has been February (average +4.34%, up in 8 of 10 years) and its weakest December (average -1.72%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NOC, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in NOC today could grow to about $20,104 by 2036 in the base case, with a 90th-percentile outcome near $57,418 and a 10th-percentile outcome around $7,039. The simulation models price only; at today's 1.91% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NOC Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $661 for NOC by 2030 in the base case, from $500 today (1.3x over 4 years). The 10th-percentile path ends near $340. These are outcomes of a Monte Carlo simulation run on NOC's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $384 | $536 | $747 | |
| 2028 | $359 | $575 | $919 | |
| 2029 | $347 | $616 | $1,095 | |
| 2030 | $340 | $661 | $1,283 | |
| 2031 | $337 | $708 | $1,488 |
Method: a lognormal simulation of NOC's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
NOC insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought NOC shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, NOC insiders reported 26 open-market sales worth $35.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Marianne Catherine Brown
Director
|
Grant | 96 | $46.4K |
| Sep 30, 2026 | Arvind Krishna
Director
|
Grant | 75 | $36.3K |
| Aug 3, 2026 | Mark A. Welsh III
Director
|
Sell | 95 | $52.0K |
| Jun 30, 2026 | Marianne Catherine Brown
Director
|
Grant | 91 | $46.3K |
| Jun 30, 2026 | Arvind Krishna
Director
|
Grant | 71 | $36.2K |
| May 20, 2026 | David P Abney
Director
|
Grant | 349 | $192.7K |
| May 20, 2026 | Marianne Catherine Brown
Director
|
Grant | 349 | $192.7K |
| May 20, 2026 | Christopher W Grady
Director
|
Grant | 349 | $192.7K |
| May 20, 2026 | Arvind Krishna
Director
|
Grant | 349 | $192.7K |
| May 20, 2026 | Kimberly A Ross
Director
|
Grant | 349 | $192.7K |
| May 20, 2026 | Gary Roughead
Director
|
Grant | 349 | $192.7K |
| May 20, 2026 | Thomas M Schoewe
Director
|
Grant | 349 | $192.7K |
| May 20, 2026 | James S Turley
Director
|
Grant | 349 | $192.7K |
| May 20, 2026 | Mark A. Welsh III
Director
|
Grant | 349 | $192.7K |
| May 20, 2026 | Mary Ann Winston
Director
|
Grant | 349 | $192.7K |
| May 4, 2026 | Mark A. Welsh III
Director
|
Sell | 95 | $54.3K |
| Mar 31, 2026 | Marianne Catherine Brown
Director
|
Grant | 68 | $46.4K |
| Mar 31, 2026 | Arvind Krishna
Director
|
Grant | 53 | $36.2K |
| Mar 2, 2026 | Kathryn G. Simpson
General Counsel
|
Sell | 873 | $650.4K |
| Feb 27, 2026 | Roshan S. Roeder
Officer
|
Sell | 1.8K | $1.3M |
| Feb 19, 2026 | Roshan S. Roeder
Officer
|
Sell | 512 | $372.5K |
| Feb 19, 2026 | Kathryn G. Simpson
General Counsel
|
Sell | 194 | $141.2K |
| Feb 19, 2026 | Michael A Hardesty
Officer
|
Sell | 147 | $107.7K |
| Feb 18, 2026 | Benjamin R Davies
Officer
|
Sell | 2.2K | $1.6M |
| Feb 17, 2026 | Kathryn G. Simpson
General Counsel
|
Sell | 779 | $547.3K |
| Feb 17, 2026 | Michael A Hardesty
Officer
|
Sell | 715 | $501.6K |
| Feb 17, 2026 | Roshan S. Roeder
Officer
|
Sell | 318 | $223.4K |
| Feb 17, 2026 | Benjamin R Davies
Officer
|
Grant | 274 | - |
| Feb 17, 2026 | Robert J Fleming
Officer
|
Grant | 264 | - |
| Feb 17, 2026 | Michael A Hardesty
Officer
|
Grant | 538 | - |
| Feb 17, 2026 | Thomas H. Jones
Officer
|
Grant | 2.2K | - |
| Feb 17, 2026 | Roshan S. Roeder
Officer
|
Grant | 2.0K | - |
| Feb 17, 2026 | Kathryn G. Simpson
General Counsel
|
Grant | 387 | - |
| Feb 17, 2026 | Kathy J Warden
Chief Executive Officer
|
Grant | 10.8K | - |
| Feb 13, 2026 | Michael A Hardesty
Officer
|
Sell | 783 | $550.4K |
| Feb 12, 2026 | Christopher W Grady
Director
|
Grant | 71 | $49.3K |
| Feb 11, 2026 | Benjamin R Davies
Officer
|
Grant | 3.2K | - |
| Feb 11, 2026 | Robert J Fleming
Officer
|
Grant | 913 | - |
| Feb 11, 2026 | Michael A Hardesty
Officer
|
Grant | 1.7K | - |
| Feb 11, 2026 | Thomas H. Jones
Officer
|
Grant | 6.9K | - |
| Feb 11, 2026 | Roshan S. Roeder
Officer
|
Grant | 6.5K | - |
| Feb 11, 2026 | Kathryn G. Simpson
General Counsel
|
Grant | 1.3K | - |
| Feb 11, 2026 | Kathy J Warden
Chief Executive Officer
|
Grant | 34.5K | - |
| Feb 6, 2026 | Kathy J Warden
Chief Executive Officer
|
Sell | 20.0K | $14.2M |
| Feb 2, 2026 | Mark A. Welsh III
Director
|
Sell | 95 | $65.0K |
| Jan 6, 2026 | Kathy J Warden
Chief Executive Officer
|
Sell | 10.0K | $6.0M |
| Dec 31, 2025 | Marianne Catherine Brown
Director
|
Grant | 81 | $46.2K |
| Dec 31, 2025 | Arvind Krishna
Director
|
Grant | 64 | $36.5K |
| Dec 9, 2025 | Roshan S. Roeder
Officer
|
Sell | 84 | $46.6K |
| Dec 5, 2025 | Roshan S. Roeder
Officer
|
Grant | 328 | - |
| Nov 24, 2025 | Mark A. Welsh III
Director
|
Sell | 97 | $54.7K |
| Sep 30, 2025 | Marianne Catherine Brown
Director
|
Grant | 76 | $46.3K |
| Sep 30, 2025 | Arvind Krishna
Director
|
Grant | 59 | $36.0K |
| Jul 17, 2025 | Thomas H. Jones
Officer
|
Sell | 729 | $382.7K |
| Jul 7, 2025 | Mark A. Welsh III
Director
|
Sell | 33 | $16.7K |
| Jun 30, 2025 | Marianne Catherine Brown
Director
|
Grant | 93 | $46.5K |
| Jun 30, 2025 | Arvind Krishna
Director
|
Grant | 73 | $36.5K |
| Jun 16, 2025 | Thomas H. Jones
Officer
|
Grant | 616 | - |
| Jun 13, 2025 | Kathy J Warden
Chief Executive Officer
|
Sell | 11.3K | $5.6M |
| Jun 13, 2025 | Robert J Fleming
Officer
|
Sell | 3.5K | $1.8M |
| Jun 13, 2025 | Thomas H. Jones
Officer
|
Sell | 729 | $368.7K |
| Jun 5, 2025 | Mark A. Welsh III
Director
|
Sell | 33 | $16.1K |
| Jun 4, 2025 | Roshan S. Roeder
Officer
|
Sell | 991 | $485.6K |
| May 30, 2025 | Thomas H. Jones
Officer
|
Sell | 729 | $349.9K |
| May 21, 2025 | David P Abney
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | Marianne Catherine Brown
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | Ann M Fudge
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | Madeleine A Kleiner
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | Arvind Krishna
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | Kimberly A Ross
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | Gary Roughead
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | Thomas M Schoewe
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | James S Turley
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | Mark A. Welsh III
Director
|
Grant | 385 | $182.5K |
| May 21, 2025 | Mary Ann Winston
Director
|
Grant | 385 | $182.5K |
| May 5, 2025 | Mark A. Welsh III
Director
|
Sell | 33 | $16.3K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.